Evidence map›Paper›PMID 41757143›Full record

ArticleEuroasian journal of hepato-gastroenterology

Outcomes and Risk Factors for Bacteriobilia in Cancer Patients Undergoing Endoscopic Retrograde Cholangiopancreatography of Malignant Biliary Obstruction at a Teaching Hospital in Northern India.

Gerlin Varghese, Mitra Kar, Ashima Jamwal, Chinmoy Sahu

Abstract read
In one paragraph

Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gerlin VargheseDepartment of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.ORCID https://orcid.org/0000-0002-4280-6681
Mitra KarDepartment of Microbiology, T.S. Mishra Medical College, Lucknow, Uttar Pradesh, India.ORCID https://orcid.org/0000-0001-9744-9653
Ashima JamwalDepartment of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.ORCID https://orcid.org/0000-0003-4497-8388
Chinmoy SahuDepartment of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.ORCID https://orcid.org/0009-0009-5501-9749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Malignant biliary obstruction (MBO) is a common complication in cases of locally or systemically advanced gastrointestinal malignancies. Placing a biliary stent is a method to relieve blockages in the biliary tract with fewer chances of bacteriobilia after endoscopic retrograde cholangiopancreatography (ERCP). Materials and methods: This retrospective study was carried out in the Department of Microbiology at a teaching hospital. The hospital information system and the case files for the ward data entry were used to collect the clinical data of every patient. Records of management using biliary drains were also analyzed. SPSS 20.0 was used for all analyses (SPSS Inc., Newark, NJ). Results: This study included 95 cancer patients undergoing ERCP. The most common tumor we encountered was advanced carcinoma gallbladder (42/95, 44.21%) and the average age of patients was 51.63 ± 12.68 years. Eighty-one bacterial isolates were isolated from the 62 patients who developed bacteriobilia. Conclusion: This study suggested increased chances of bacteriobilia and MDR due to prolonged placement of the biliary stenting following ERCP. How to cite this article: Varghese G, Kar M, Jamwal A,

Indexed as

Biliary stentCancer patientsCholecystitisEndoscopic retrograde cholangiopancreatographyMalignant biliary obstruction

Identifiers

PMID41757143
PMCPMC12932376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.